|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
GB0031109D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7105551B2
(en)
|
2000-12-20 |
2006-09-12 |
Smithkline Beecham Corporation |
Thiazole derivatives for treating PPAR related disorders
|
|
ATE325608T1
(de)
|
2001-08-13 |
2006-06-15 |
Janssen Pharmaceutica Nv |
2,4,5-trisubstituted thiazolyl derivative und deren antiinflammatorische wirkung
|
|
US7259175B2
(en)
|
2002-02-25 |
2007-08-21 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
GB0214139D0
(en)
*
|
2002-06-19 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
BR0314335A
(pt)
|
2002-09-05 |
2005-07-26 |
Novo Nordisk As |
Composto, uso do mesmo, composição farmacêutica, e métodos para o tratamento e/ou prevenção de condições mediadas por receptores nucleares, e de diabetes de tipo i, diabetes de tipo ii, tolerância prejudicada à glicose, resistência à insulina ou obesidade
|
|
JP2005035966A
(ja)
*
|
2002-09-06 |
2005-02-10 |
Takeda Chem Ind Ltd |
フランまたはチオフェン誘導体およびその医薬用途
|
|
AU2003261935A1
(en)
*
|
2002-09-06 |
2004-03-29 |
Takeda Pharmaceutical Company Limited |
Furan or thiophene derivative and medicinal use thereof
|
|
AU2003267297A1
(en)
*
|
2002-09-19 |
2004-04-08 |
Smithkline Beecham Corporation |
Process for preparing substituted phenoxy-acetic acids from phenols
|
|
DE60332860D1
(de)
|
2002-10-28 |
2010-07-15 |
High Point Pharmaceuticals Llc |
Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen
|
|
DE60333211D1
(de)
|
2002-10-28 |
2010-08-12 |
High Point Pharmaceuticals Llc |
Neue verbindungen und deren verwendung als ppar-modulatoren
|
|
US7129268B2
(en)
|
2002-10-28 |
2006-10-31 |
Novo Nordisk A/S |
Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
|
|
US20050080115A1
(en)
|
2002-10-28 |
2005-04-14 |
Lone Jeppesen |
Novel compounds, their preparation and use
|
|
DE10308355A1
(de)
*
|
2003-02-27 |
2004-12-23 |
Aventis Pharma Deutschland Gmbh |
Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
ES2352085T3
(es)
|
2004-05-05 |
2011-02-15 |
High Point Pharmaceuticals, Llc |
Nuevos compuestos, su preparación y uso.
|
|
WO2005105736A1
(en)
|
2004-05-05 |
2005-11-10 |
Novo Nordisk A/S |
Novel compounds, their preparation and use
|
|
KR20080014075A
(ko)
*
|
2005-05-25 |
2008-02-13 |
닛뽕 케미파 가부시키가이샤 |
페록시좀 증식제 활성화 수용체의 활성화제
|
|
ATE529404T1
(de)
|
2005-06-30 |
2011-11-15 |
High Point Pharmaceuticals Llc |
Phenoxyessigsäuren als ppar-delta-aktivatoren
|
|
BRPI0620468A2
(pt)
|
2005-12-22 |
2011-11-08 |
Transtech Pharma, Inc. |
ácidos fenóxi acéticos como ativadores de ppar delta
|
|
JP2009132620A
(ja)
*
|
2006-03-07 |
2009-06-18 |
Astellas Pharma Inc |
フェニルチアゾール誘導体
|
|
WO2007101864A2
(en)
|
2006-03-09 |
2007-09-13 |
High Point Pharmaceuticals, Llc |
Compounds that modulate ppar activity, their preparation and use
|
|
CN101466687B
(zh)
|
2006-04-18 |
2012-04-11 |
日本化学医药株式会社 |
过氧化物酶体增殖剂激活受体δ的激活剂
|
|
WO2008028914A1
(en)
|
2006-09-07 |
2008-03-13 |
Nycomed Gmbh |
Combination treatment for diabetes mellitus
|
|
FR2910893A1
(fr)
*
|
2006-12-29 |
2008-07-04 |
Genfit Sa |
Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazolyl)-phenyl-propan-1-one substitues, preparations et utilisations.
|
|
KR101560844B1
(ko)
|
2007-06-04 |
2015-10-15 |
벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 |
트라이-아릴계 화합물 및 이를 포함하는 조성물
|
|
EP2277874B1
(en)
|
2008-04-15 |
2018-06-27 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-activated receptor
|
|
US20120094959A1
(en)
|
2010-10-19 |
2012-04-19 |
Bonnie Blazer-Yost |
Treatment of cystic diseases
|
|
US9688673B2
(en)
|
2011-03-08 |
2017-06-27 |
The Regents Of The University Of California |
Deoxycytidine kinase binding compounds
|
|
WO2015035171A1
(en)
|
2013-09-09 |
2015-03-12 |
High Point Pharmaceuticals, Llc |
Use of a ppar-delta agonist for treating muscle atrophy
|
|
MX2016005995A
(es)
|
2013-11-05 |
2016-08-17 |
Ben-Gurion Univ Of The Negev Res And Dev Authority |
Compuestos para el tratamiento de diabetes y complicaciones de la enfermedad derivadas de la misma.
|
|
EP4075980B1
(en)
|
2019-12-18 |
2025-07-23 |
Stinginn LLC |
Substituted 1,2, 4-triazoles and methods of use
|
|
WO2022094409A1
(en)
|
2020-11-02 |
2022-05-05 |
Trethera Corporation |
Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof
|
|
JP2024521048A
(ja)
*
|
2021-05-19 |
2024-05-28 |
スティンジン，インコーポレイテッド |
Ｓｔｉｎｇシグナル伝達組成物の小分子阻害剤および使用の方法
|
|
WO2023147309A1
(en)
|
2022-01-25 |
2023-08-03 |
Reneo Pharmaceuticals, Inc. |
Use of ppar-delta agonists in the treatment of disease
|